Product Recalls in New Mexico

Product recalls affecting New Mexico — including food, drugs, consumer products, medical devices, and vehicles distributed to New Mexico. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,585 recalls have been distributed to New Mexico in the last 12 months.

48,595 total recalls
2,585 in last 12 months

Showing 46414660 of 13,432 recalls

DrugMarch 9, 2020· Sun Pharmaceutical Industries, Inc.

Recalled Item: Atorvastatin Calcium Tablets Recalled by Sun Pharmaceutical Industries, Inc....

The Issue: Presence of foreign substance: Foreign matter has been identified as latex...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 6, 2020· H J Harkins Company Inc dba Pharma Pac

Recalled Item: Acetaminophen 500 mg tablet packaged in a) 30-count bottles ( NDC...

The Issue: Presence of Foreign Tablets/Capsules: Complaint involving one Women's...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 4, 2020· Par Pharmaceutical Inc.

Recalled Item: PrediniSONE Tablets Recalled by Par Pharmaceutical Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 3, 2020· Yusef Manufacturing Laboratories, LLC

Recalled Item: PEPPERMINT LIP MOISTURIZER (oxybenzone (4%) and Octinoxate (7%) SPF 15...

The Issue: Superpotent drug: This lot of SPF containing lip balm contains up to 150% of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Mayne Pharma Inc

Recalled Item: Carbidopa and Levodopa Tablets Recalled by Mayne Pharma Inc Due to Product...

The Issue: Product Mix-Up: A foreign tablet was found in bottle.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· Pfizer Inc.

Recalled Item: Elelyso (taliglucerase alfa) for injection Recalled by Pfizer Inc. Due to...

The Issue: Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL) Recalled by Breckenridge...

The Issue: Failed Impurities/Degradation Specifications: Out-of-specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: Well at Walgreens Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn,...

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to...

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: CVS Health Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn, Inc....

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2020· Teva Pharmaceuticals USA

Recalled Item: Mesalamine Delayed-Release Tablets Recalled by Teva Pharmaceuticals USA Due...

The Issue: Failed Dissolution Specifications: Low out of specification dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 17, 2020· Strides Pharma Science Limited

Recalled Item: Potassium Chloride Extended-Release Tablets USP Recalled by Strides Pharma...

The Issue: Failed Tablet/Capsules Specifications: Oversized tablets were found in one...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund